Procurement of Actimmune

Added: Jul 28, 2016 4:15 pm This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) intends to award a Fixed Price Purchase Order to Priority Healthcare Distribution, Inc, DBA: Curascript SD 255 Techniology Park, Lake Mary, FL 32746, on a sole source basis to procure the pharmaceutical Actimmune® as necessary to fulfill the requirements of patient need and protocols underway at the NIH, Clinical Center. The Government intends to purchase a minimum of six (6) boxes, 12 vials, 100 mcg each, in each box, with the option to purchase up to eight (8) more boxes, twelve vials each within a 12 month Period of Performance. At this time, the manufacturer of Actimmune® has designated Curascript SD as the only authorized distributor of Actimmune®.
This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12 in conjunction with the policies and procedures for the competition requirements in FAR Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Lisa Schaupp, Contract Specialist, Lisa.Schaupp@nih.gov, by the due date and time marked in this notice.